{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:52:10Z","timestamp":1790952730456,"version":"4.1.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jdin.2025.09.005","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:04:32Z","timestamp":1759345472000},"page":"64-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Oral tranexamic acid use for melasma is not associated with thromboembolism: Findings from a multicenter propensity score\u2013matched electronic health record cohort"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4999-5488","authenticated-orcid":false,"given":"Tyler","family":"Hernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Penny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Culotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdin.2025.09.005_bib1","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/jocd.16104","article-title":"Comparative efficacy and safety of tranexamic acid for melasma by different administration methods: a systematic review and network meta-analysis","volume":"23","author":"Liang","year":"2024","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2025.09.005_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2016.03.001","article-title":"Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis","volume":"75","author":"Lee","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdin.2025.09.005_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jdin.2024.03.006","article-title":"Oral tranexamic acid treatment beyond 6 months for melasma patients - a retrospective case series","volume":"15","author":"Lam","year":"2024","journal-title":"JAAD Int"},{"issue":"4","key":"10.1016\/j.jdin.2025.09.005_bib4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaad.2025.06.001","article-title":"No thromboembolic events observed in randomized controlled trials of oral tranexamic acid: a systematic review and descriptive synthesis","volume":"93","author":"Kuceki","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdin.2025.09.005_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100882","article-title":"Oral tranexamic acid and thrombosis risk in women","volume":"35","author":"Meaidi","year":"2021","journal-title":"EClinicalMedicine"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328725001142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328725001142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T08:39:35Z","timestamp":1770626375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328725001142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":5,"alternative-id":["S2666328725001142"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2025.09.005","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral tranexamic acid use for melasma is not associated with thromboembolism: Findings from a multicenter propensity score\u2013matched electronic health record cohort","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2025.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}